NLRP3 and cancer: This divergence may reflect structural differences influencing enzyme binding, as verbascoside and related PEs have recently been shown to interact with NF-κB and NLRP3 inflammasome targets [24], suggesting that their role in inflammation-related cancer pathways may be broader than previously recognized.